Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1950 1
1951 3
1952 2
1953 3
1954 7
1955 1
1956 2
1957 6
1958 4
1959 1
1960 2
1961 13
1962 20
1963 20
1964 23
1965 19
1966 25
1967 29
1968 30
1969 24
1970 30
1971 30
1972 29
1973 33
1974 32
1975 31
1976 38
1977 37
1978 41
1979 45
1980 63
1981 64
1982 66
1983 78
1984 95
1985 98
1986 99
1987 87
1988 100
1989 113
1990 102
1991 105
1992 121
1993 109
1994 98
1995 124
1996 179
1997 166
1998 200
1999 174
2000 216
2001 206
2002 205
2003 218
2004 215
2005 229
2006 274
2007 259
2008 288
2009 265
2010 279
2011 278
2012 328
2013 328
2014 301
2015 285
2016 280
2017 285
2018 320
2019 319
2020 355
2021 410
2022 383
2023 391
2024 384
2025 335
2026 3

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

9,672 results

Results by year

Filters applied: . Clear all
Page 1
TOKYO criteria 2024 for the assessment of clinical outcomes of endoscopic biliary drainage.
Isayama H, Hamada T, Fujisawa T, Fukasawa M, Hara K, Irisawa A, Ishii S, Ito K, Itoi T, Kanno Y, Katanuma A, Kato H, Kawakami H, Kawamoto H, Kitano M, Kogure H, Matsubara S, Mukai T, Naitoh I, Ogura T, Ryozawa S, Sasaki T, Shimatani M, Shiomi H, Sugimori K, Takenaka M, Yasuda I, Nakai Y, Fujita N, Inui K; Research Group of Evaluation Criteria for Endoscopic Biliary Drainage. Isayama H, et al. Among authors: sasaki t. Dig Endosc. 2024 Nov;36(11):1195-1210. doi: 10.1111/den.14825. Epub 2024 Jun 6. Dig Endosc. 2024. PMID: 38845085 Review.
Shoulder stretching versus shoulder muscle strength training for the prevention of baseball-related arm injuries: a randomized, active-controlled, open-label, non-inferiority study.
Shitara H, Tajika T, Kuboi T, Ichinose T, Sasaki T, Hamano N, Kamiyama M, Yamamoto A, Kobayashi T, Takagishi K, Chikuda H. Shitara H, et al. Among authors: sasaki t. Sci Rep. 2022 Dec 21;12(1):22118. doi: 10.1038/s41598-022-26682-1. Sci Rep. 2022. PMID: 36543874 Free PMC article. Clinical Trial.
Randomized controlled trial on the skin toxicity of panitumumab in Japanese patients with metastatic colorectal cancer: HGCSG1001 study; J-STEPP.
Kobayashi Y, Komatsu Y, Yuki S, Fukushima H, Sasaki T, Iwanaga I, Uebayashi M, Okuda H, Kusumi T, Miyagishima T, Sogabe S, Tateyama M, Hatanaka K, Tsuji Y, Nakamura M, Konno J, Yamamoto F, Onodera M, Iwai K, Sakata Y, Abe R, Oba K, Sakamoto N. Kobayashi Y, et al. Among authors: sasaki t. Future Oncol. 2015;11(4):617-27. doi: 10.2217/fon.14.251. Future Oncol. 2015. PMID: 25686117 Clinical Trial.
Congenital nasolacrimal duct obstruction: clinical guideline.
Sasaki T, Matsumura N, Miyazaki C, Kamao T, Yokoi N, Fujimoto M, Hayami M, Iwasaki A, Mimura M, Murata A, Nakayama T, Shinomiya K, Tanaka H, Ueta Y; Congenital Nasolacrimal Duct Obstruction: Clinical Guideline Preparation Team; Committee for Congenital Nasolacrimal Duct Obstruction Clinical Guideline. Sasaki T, et al. Jpn J Ophthalmol. 2024 Jul;68(4):367-388. doi: 10.1007/s10384-024-01064-4. Epub 2024 Aug 16. Jpn J Ophthalmol. 2024. PMID: 39150609 No abstract available.
Efficacy and Safety of Durvalumab/Tremelimumab in Unresectable Hepatocellular Carcinoma as Immune Checkpoint Inhibitor Rechallenge Following Atezolizumab/Bevacizumab Treatment.
Sho T, Suda G, Ohara M, Kohya R, Sasaki T, Yoshida S, Hosoda S, Ogawa K, Kitagataya T, Maehara O, Ohnishi S, Kawagishi N, Natsuizaka M, Nakai M, Baba M, Yamamoto Y, Tsukuda Y, Meguro T, Yamada R, Kobayashi T, Takagi T, Sakamoto N; NORTE STUDY GROUP. Sho T, et al. Among authors: sasaki t. Target Oncol. 2024 Sep;19(5):769-778. doi: 10.1007/s11523-024-01092-7. Epub 2024 Sep 2. Target Oncol. 2024. PMID: 39222223
Temporally resolved proteomics identifies nidogen-2 as a cotarget in pancreatic cancer that modulates fibrosis and therapy response.
Pereira BA, Ritchie S, Chambers CR, Gordon KA, Magenau A, Murphy KJ, Nobis M, Tyma VM, Liew YF, Lucas MC, Naeini MM, Barkauskas DS, Chacon-Fajardo D, Howell AE, Parker AL, Warren SC, Reed DA, Lee V, Metcalf XL, Lee YK, O'Regan LP, Zhu J, Trpceski M, Fontaine ARM, Stoehr J, Rouet R, Lin X, Chitty JL, Porazinski S, Wu SZ, Filipe EC, Cadell AL, Holliday H, Yang J, Papanicolaou M, Lyons RJ, Zaratzian A, Tayao M, Da Silva A, Vennin C, Yin J, Dew AB, McMillan PJ, Goldstein LD, Deveson IW, Croucher DR, Samuel MS, Sim HW, Batten M, Chantrill L, Grimmond SM, Gill AJ, Samra J, Jeffry Evans TR, Sasaki T, Phan TG, Swarbrick A, Sansom OJ, Morton JP; Australian Pancreatic Cancer Matrix Atlas (APMA); Australian Pancreatic Cancer Genome Initiative (APGI); Pajic M, Parker BL, Herrmann D, Cox TR, Timpson P. Pereira BA, et al. Among authors: sasaki t. Sci Adv. 2024 Jul 5;10(27):eadl1197. doi: 10.1126/sciadv.adl1197. Epub 2024 Jul 3. Sci Adv. 2024. PMID: 38959305 Free PMC article.
TNF is a potential therapeutic target to suppress prostatic inflammation and hyperplasia in autoimmune disease.
Vickman RE, Aaron-Brooks L, Zhang R, Lanman NA, Lapin B, Gil V, Greenberg M, Sasaki T, Cresswell GM, Broman MM, Paez JS, Petkewicz J, Talaty P, Helfand BT, Glaser AP, Wang CH, Franco OE, Ratliff TL, Nastiuk KL, Crawford SE, Hayward SW. Vickman RE, et al. Among authors: sasaki t. Nat Commun. 2022 Apr 19;13(1):2133. doi: 10.1038/s41467-022-29719-1. Nat Commun. 2022. PMID: 35440548 Free PMC article.
9,672 results